Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heiko Huber

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Journal of Neurology|November 6, 2013
Risk factors and prodromal markers and the development of Parkinson's diseaseStefanie Lerche, Klaus Seppi, Stefanie Behnke, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 2, 2012
Enlarged hyperechogenic substantia nigra as a risk marker for Parkinson's diseaseDaniela Berg, Stefanie Behnke, Klaus Seppi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 13, 2011
AFQ056 treatment of levodopa-induced dyskinesias: results of 2 randomized controlled trialsDaniela Berg, Jana Godau, Claudia Trenkwalder, et al.
Archives of Neurology|July 13, 2011
Enlarged substantia nigra hyperechogenicity and risk for Parkinson disease: a 37-month 3-center study of 1847 older personsDaniela Berg, Klaus Seppi, Stefanie Behnke, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Journal of Neurology|November 6, 2013
Risk factors and prodromal markers and the development of Parkinson's diseaseStefanie Lerche, Klaus Seppi, Stefanie Behnke, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 2, 2012
Enlarged hyperechogenic substantia nigra as a risk marker for Parkinson's diseaseDaniela Berg, Stefanie Behnke, Klaus Seppi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 13, 2011
AFQ056 treatment of levodopa-induced dyskinesias: results of 2 randomized controlled trialsDaniela Berg, Jana Godau, Claudia Trenkwalder, et al.
Archives of Neurology|July 13, 2011
Enlarged substantia nigra hyperechogenicity and risk for Parkinson disease: a 37-month 3-center study of 1847 older personsDaniela Berg, Klaus Seppi, Stefanie Behnke, et al.
Pageof 2